Literature DB >> 3538477

Intravenous aminophylline in patients already taking oral theophylline: effect on calculated dose of knowledge of serum theophylline concentration on admission.

J Wiggins, O A Arbab, D E Stableforth, J G Ayres.   

Abstract

Measurement of serum theophylline concentration is usually recommended before intravenous aminophylline is given to patients taking oral theophylline. Fifty patients with worsening airflow obstruction, all of whom were taking oral theophyllines and who had no contraindication to the use of parenteral aminophylline, were randomly allocated into two groups before treatment was given. The dose of aminophylline was calculated without (group A) and with (group B) knowledge of admission serum theophylline concentration. In group A a regimen incorporating corrections to account for factors affecting theophylline clearance was used in an attempt to represent a "knowledgeable" approach; in group B a formula incorporating the known serum theophylline concentration at the time of admission was used. All loading doses were given over 30 minutes as "mini infusions." The two groups were well matched for age, blood gas tensions, and severity of airflow obstruction. The results for four patients (one from group A and three from group B) were excluded from analysis after completion of the study. In each group the mean admission serum theophylline concentration measured (group A: 8.4 (SD 6.0)mg/l; group B: 7.2 (5.7)mg/l) and the aminophylline doses used (group A: loading bolus 172 (45.5)mg, infusion 815 (198)mg; group B: loading bolus 233(189)mg, infusion 788(214)mg) were similar. Mean serum theophylline concentrations during 24 hours' aminophylline treatment, number of patients with a serum theophylline concentration greater than 20 mg/l, symptoms of toxicity, and outcome were also similar in the two groups. Although satisfactory use of parenteral aminophylline was achieved for most patients without knowledge of serum theophylline concentration at the time of admission to hospital (with the aid of a "knowledgeable" clinical approach and constant infusion pumps), prompt measurement of serum theophylline concentration at the time of admission identified patients with either suboptimal or potentially hazardous theophylline concentrations.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3538477      PMCID: PMC460473          DOI: 10.1136/thx.41.10.759

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  16 in total

1.  Effect of smoking on theophylline disposition.

Authors:  S N Hunt; W J Jusko; A M Yurchak
Journal:  Clin Pharmacol Ther       Date:  1976-05       Impact factor: 6.875

2.  Clinical experience with theophylline. Relarionships between dosage, serum concentration, and toxicity.

Authors:  M H Jacobs; R M Senior; G Kessler
Journal:  JAMA       Date:  1976-05-03       Impact factor: 56.272

3.  Intravenous aminophylline dosage. Use of serum theophylline measurement for guidance.

Authors:  M W Weinberger; R A Matthay; E J Ginchansky; C A Chidsey; T L Petty
Journal:  JAMA       Date:  1976-05-10       Impact factor: 56.272

4.  Pharmacokinetics of theophylline. Application to adjustment of the clinical dose of aminophylline.

Authors:  J W Jenne; M S Wyze; F S Rood; F M MacDonald
Journal:  Clin Pharmacol Ther       Date:  1972 May-Jun       Impact factor: 6.875

5.  Rapid prediction of steady-state serum theophylline concentration in patients treated with intravenous aminophylline.

Authors:  S Vozeh; G Kewitz; M Wenk; F Follath
Journal:  Eur J Clin Pharmacol       Date:  1980-11       Impact factor: 2.953

6.  Disposition of theophylline after a single intravenous infusion of aminophylline.

Authors:  L Hendeles; M Weinberger; L Bighley
Journal:  Am Rev Respir Dis       Date:  1978-07

7.  Method for the rapid estimation of the total body drug clearance and adjustment of dosage regimens in patients during a constant-rate intravenous infusion.

Authors:  W L Chiou; M A Gadalla; G W Peng
Journal:  J Pharmacokinet Biopharm       Date:  1978-04

8.  Theophylline disposition in acutely ill hospitalized patients. The effect of smoking, heart failure, severe airway obstruction, and pneumonia.

Authors:  J R Powell; S Vozeh; P Hopewell; J Costello; L B Sheiner; S Riegelman
Journal:  Am Rev Respir Dis       Date:  1978-08

9.  The use of parenteral aminophylline in patients taking slow release theophylline preparations: an observation of clinical practice.

Authors:  O A Arbab; J Wiggins; J G Ayres; D E Stableforth
Journal:  Br J Dis Chest       Date:  1985-04

10.  Theophylline disposition in obesity.

Authors:  P Gal; W J Jusko; A M Yurchak; B A Franklin
Journal:  Clin Pharmacol Ther       Date:  1978-04       Impact factor: 6.875

View more
  1 in total

1.  Aminophylline infusion in acute severe asthma: where do we go from here?

Authors:  S R Lloyd; A Sharma
Journal:  Can Fam Physician       Date:  1990-05       Impact factor: 3.275

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.